Related Experiment Video

Updated: Aug 14, 2026

Isolation of Atrial Myocytes from Adult Mice
08:34

Isolation of Atrial Myocytes from Adult Mice

Published on: July 25, 2019

Circulating B-type natriuretic peptides in patients with acute coronary syndromes. Pathophysiological, prognostical

Rudolf Jarai1, Johann Wojta, Kurt Huber

  • 1Wilhelminenhospital, 3rd Department of Medicine, Cardiology and Emergency Medicine, Vienna, Austria.

Thrombosis and Haemostasis
|December 21, 2005
PubMed

Insights

Elevated B-type natriuretic peptides in acute coronary syndromes (ACS) are common but don't indicate permanent heart failure. Further research is needed to understand mechanisms and guide treatment for this high-risk group.

Area of Science:

  • Cardiology
  • Biomarkers
  • Acute Coronary Syndromes

Background:

  • Elevated plasma B-type natriuretic peptides (BNP/Nt-proBNP) are observed in 50% of patients experiencing death or heart failure post-acute coronary syndromes (ACS).
  • These peptide elevations may precede or coincide with ischemic symptoms, not necessarily reflecting established ventricular dysfunction.

Purpose of the Study:

  • To investigate the unknown mechanisms behind BNP/Nt-proBNP elevations in ACS patients.
  • To clarify the relationship between elevated BNP/Nt-proBNP, mortality, and atherothrombotic complications to inform therapeutic strategies.

Main Methods:

  • Analysis of plasma BNP/Nt-proBNP concentrations in ACS patients.
  • Correlation of peptide levels with clinical outcomes including mortality and atherothrombotic events.
  • Investigation into potential pathomechanisms underlying peptide elevations.

Main Results:

  • Extremely elevated BNP/Nt-proBNP concentrations are prevalent in high-risk ACS patients.
  • The elevations do not consistently correlate with permanent ventricular dysfunction or heart failure.
  • A strong association exists between elevated BNP/Nt-proBNP and both short- and long-term mortality, independent of atherothrombotic complications.

Conclusions:

  • The mechanisms driving BNP/Nt-proBNP elevations in ACS remain unclear.
  • Elevated BNP/Nt-proBNP identifies a high-risk ACS population requiring focused investigation.
  • Further research is crucial to elucidate pathomechanisms and develop targeted therapies for this group.

More Related Videos

Cardiac Loading using Passive Left Atrial Pressurization and Passive Afterload for Graft Assessment08:49

Cardiac Loading using Passive Left Atrial Pressurization and Passive Afterload for Graft Assessment

Published on: August 2, 2024

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...